Redmile Group »

Verve Therapeutics shares owned by Redmile Group

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Redmile Group from 13F filings

Historical chart of Redmile Group investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Redmile Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Redmile Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $24M 1.7M 13.94
2023-09-30 $11M 810k 13.26
2023-06-30 $20M 1.1M 18.75
2023-03-31 $16M 1.1M 14.42
2022-12-31 $24M 1.2M 19.35
2022-09-30 $52M 1.5M 34.35
2022-06-30 $28M 1.8M 15.28
2022-03-31 $42M 1.8M 22.82
2021-12-31 $63M 1.7M 36.87
2021-09-30 $88M 1.9M 47.00
2021-06-30 $117M 1.9M 60.25